Provera (Medroxyprogesterone) Withdrawal Bleed Timing: What to Expect

After a 10-day course of medroxyprogesterone acetate (MPA) 10 mg daily, withdrawal bleeding typically occurs 3–7 days after the last dose, though 1–14 days is the reported range.

Mechanism

  • MPA provides progestogenic priming → endometrial stabilization.
  • Upon cessation, progesterone withdrawal → spiral artery vasoconstriction → endometrial shedding (withdrawal bleed).
  • Requires adequate estrogen priming (endometrial thickness >5–7 mm) to occur.

Factors Affecting Timing

  • Endometrial thickness: Thin lining (atrophy, hypoestrogenism) → no bleed or delayed/scant.
  • Underlying condition: PCOS (often thickened) → reliable bleed; hypothalamic amenorrhea (thin) → may not bleed.
  • Concurrent medications: Other hormones, anticoagulants.
  • Individual variation in metabolism/clearance.

Clinical Interpretation

  • Bleed occurs: Estrogen present, outflow tract patent → rules out outflow obstruction (Asherman's, cervical stenosis).
  • No bleed: Suggests hypoestrogenism (check estradiol, FSH) or outflow obstruction → evaluate with ultrasound ± hysteroscopy.
  • Bleed ≠ ovulation: Withdrawal bleed is progesterone-withdrawal, not follicular maturation.

Patient Guidance

  • Complete the full prescribed course (usually 5–10 days).
  • Expect bleed 3–7 days post-course; up to 2 weeks is normal.
  • If no bleed by 14 days → contact provider for assessment (pregnancy test, estradiol, ultrasound).
  • If pregnant, MPA not teratogenic but not indicated — stop and confirm.

MPA challenge is a diagnostic tool, not a treatment for infertility. Discuss results with your clinician.

Back Pain - Related Articles